254
Biophysical Society 59
th
Annual Meeting, Baltimore, Maryland
Name
Disclosure Entity
Disclosure Type
Presentation Number
Large, Charles
Autifony Therapeutics Limited Employment (full or part-time) in funding company 635-Pos
Law, Richard
Evotec (U.K.) Ltd.
Employment (full or part-time) in funding company 1791-Plat
Lazar, Josef
Innovative Bioimaging, LLC Stock options or bond holdings in a for-profit corpo-
ration or self-directed pension plan
1643-Pos
Lee, Jo
UCB Pharma
Research funded by industry grant
1548-Pos
Li, Jiali
NIHGrant
Other
874-Pos
Liang, Qiansheng
Autifony Therapeutics Limited Research funded by industry grant
635-Pos
Liao, Jinfang
AAT Bioquest
Employment (full or part-time) in funding company 549-Pos
Lin, Kun-Han
Cytocentrics Bioscience GmbH Employment (full or part-time) in funding company 2954-Pos
Liu, Zhiqi
ChanTest
Employment (full or part-time) in funding company 2955-Pos
Livesay, Dennis
MedImmune Ltd
Research funded by industry grant
1893-Pos
Louttit, James
GlaxoSmithKline
Employment (full or part-time) in funding company 605-Pos
Ludescher, Richard
Pepsi Co.
Research funded by industry grant
3139-Pos
Ma, Jianjie
Founder of Trim-edicine
Other
1346-Pos
Mangan, Kile
CDI
Employment (full or part-time) in funding company 2968-Pos
Mayer, Michael
Oxford Nanopore
Research funded by industry grant
872-Pos
Mayer, Michael
Oxford Nanopores Technologies
Ltd
Research funded by industry grant
876-Pos
McKay, Craig
Molecular Devices, LLC
Employment (full or part-time) in funding company 1434-Pos
McLachlan, Michael
CDI
Employment (full or part-time) in funding company 2968-Pos
McNabb, David
NIHGrant
Other
874-Pos
Meline, Benjamin
CDI
Employment (full or part-time) in funding company 3014-Pos
Meline, Benjamin
CDI
Employment (full or part-time) in funding company 2968-Pos
Mellman, Ira
Genentech, Incorporated, a
member of the Roche Group
Employment (full or part-time) in funding company 810-Pos
Melosh, Nicholas
Stealth Biosciences
Stock options or bond holdings in a for-profit corpo-
ration or self-directed pension plan
743-Pos
Melosh, Nicholas
Stealth Biosciences
Stock options or bond holdings in a for-profit corpo-
ration or self-directed pension plan
2876-Pos
Meyer, Nathan
CDI
Ownership or Partnership in funding organization 2968-Pos
Mirams, Gary
GlaxoSmithKline
Research funded by industry grant
605-Pos
Miu, Peter
Molecular Devices, LLC
Employment (full or part-time) in funding company 1434-Pos
Moss, Richard
Consultant for Myokardia, Inc.
Consulting fees or other remuneration from industry 663-Pos
Nandivada, Santoshi
NIHGrant
Other
874-Pos
Narain, Niven
Berg LLC
Ownership or Partnership in funding organization 1243-Pos
Nelson, Philip
WH Freeman and Co.
Receipt of royalties from referenced company
products
1673-Pos
Obejero-Paz, Carlos
ChanTest Corporation
Employment (full or part-time) in funding company 2945-Pos
Ozcan, Aydogan
Holomic LLC
Non-remunerative positions of influence such as
officer, board member, trustee, or public spokesper-
son in company
1861-Wkshp
Peterman, Erwin
LUMICKS
Receipt of royalties from referenced company
products
2557-Plat
Peterman, Erwin
LUMICKS
Stock options or bond holdings in a for-profit corpo-
ration or self-directed pension plan
832-Pos
Peterson, Raymond
Celadon Laboratories
Employment (full or part-time) in funding company 1985-Pos